Tiếp theo

Tự chạy

When should one consider tyrosine kinase inhibitor therapy for medullary thyroid cancer? 153

0 Lượt xem • 07/10/23
Đăng lại
Nhúng
administrator
administrator
Người đăng ký
0

Originally presented at the 23rd International Thyroid Cancer Survivors’ Virtual Conference held October 23-25, 2020.
When should one consider tyrosine kinase inhibitor therapy for medullary thyroid cancer? Robert F. Gagel, MD, Endocrinologist, and Mark E. Zafereo, MD, Head and Neck Surgeon.

Cho xem nhiều hơn
0 Bình luận sort Sắp xếp theo
Bình luận trên Facebook

Tiếp theo

Tự chạy